PTFE or HUV for femoro-popliteal bypass: a multi-centre trial.

[1]  C. McCollum,et al.  Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. , 1991, Journal of vascular surgery.

[2]  C. McCollum,et al.  The influence of smoking and plasma factors on prosthetic graft patency. , 1990, European journal of vascular surgery.

[3]  A. Nicolaides,et al.  Femorodistal vein bypass graft stenoses , 1988, The British journal of surgery.

[4]  Van Vroonhoven Tj,et al.  PTFE versus human umbilical vein in above knee femoro-popliteal bypass. Early results of a randomized clinical trial. , 1988 .

[5]  A. Dardik,et al.  A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb. , 1988, Journal of vascular surgery.

[6]  L. Norgren,et al.  Four years' results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal bypass. , 1987, Journal of vascular surgery.

[7]  Buchardt Hansen Hj,et al.  Umbilical vein bypass in patients with severe lower limb ischemia: a report of 121 consecutive cases. , 1985 .

[8]  F. Jarrett,et al.  The use of stabilized human umbilical vein for femoropopliteal bypass. Experience with 133 operations with 5-year follow-up. , 1984, Annals of surgery.

[9]  J. May,et al.  Limitations of human umbilical vein grafts. , 1984, Surgery.

[10]  D. Raithel,et al.  Late results with Dardik-biograft in peripheral arterial surgery. , 1984, The Journal of cardiovascular surgery.

[11]  C. Mccollum,et al.  Does 111indium‐platelet deposition predict patency in prosthetic arterial grafts? , 1983, The British journal of surgery.

[12]  W. Abbott,et al.  Femoropopliteal and tibioperoneal artery reconstruction using human umbilical vein. , 1983, Archives of surgery.

[13]  J. S. Yao,et al.  Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction. , 1982, Surgery.

[14]  R. Green,et al.  Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency. , 1982, Surgery.

[15]  B. Dubner,et al.  Comparative review of early and intermediate patency rates of polytetrafluoroethylene and autogenous saphenous vein grafts for lower extremity ischemia. , 1981, Surgery.

[16]  J. Sladen,et al.  Experience with 130 polytetrafluoroethylene grafts. , 1981, American journal of surgery.

[17]  R. Weisel,et al.  Comparison of conduits for leg revascularization. , 1981, Surgery.

[18]  F. Veith,et al.  Three year experience with expanded polytetrafluoroethylene arterial grafts for limb salvage. , 1980, American journal of surgery.

[19]  F. Veith,et al.  Management of early and late thrombosis of expanded polytetrafluoroethylene (PTFE) femoropopliteal bypass grafts: favorable prognosis with appropriate reoperation. , 1980, Surgery.

[20]  I. Dardik,et al.  Three‐year experience with glutaraldehyde‐stabilized umbilical vein for limb salvage , 1980, The British journal of surgery.

[21]  I. Dardik,et al.  Successful Arterial Substitution with Modified Human Umbilical Vein , 1976, Annals of surgery.

[22]  M. Saigusa,et al.  A new vascular prosthesis for a small caliber artery. , 1973, Surgery.